Clinical Trials Browser

Phase 1/2 × Lung Neoplasms × Fluorodeoxyglucose F18 × Clear all

NCT05501665 2024-10-17

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02481726 2015-06-25

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Phase 1/2 Completed

Lung Neoplasms, Tuberculosis, Pulmonary